End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2809 USD | -8.65% | -6.74% | -57.44% |
Mar. 21 | Senti Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 21 | Earnings Flash (SNTI) SENTI BIOSCIENCES Reports 2023 Revenue $2.6M | MT |
Financials (USD)
Sales 2022 | 4.29M | Sales 2023 | 2.56M | Capitalization | 29.4M |
---|---|---|---|---|---|
Net income 2022 | -58M | Net income 2023 | -71M | EV / Sales 2022 | -0.25 x |
Net cash position 2022 | 62.89M | Net Debt 2023 | 1.7M | EV / Sales 2023 | 12.1 x |
P/E ratio 2022 |
-0.63
x | P/E ratio 2023 |
-0.41
x | Employees | 48 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.6% |
1 day | +6.03% | ||
1 week | +2.09% | ||
Current month | -18.46% | ||
1 month | -29.92% | ||
3 months | -27.12% | ||
6 months | -8.48% | ||
Current year | -53.41% |
Managers | Title | Age | Since |
---|---|---|---|
Timothy Lu
FOU | Founder | 43 | 16-06-08 |
Director of Finance/CFO | 51 | 21-04-30 | |
Kanya Rajangam
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Berland
BRD | Director/Board Member | 69 | 21-05-31 |
Director/Board Member | 64 | 16-06-30 | |
Omid Farokhzad
BRD | Director/Board Member | 55 | 22-06-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.18% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 0.2809 | -8.65% | 92,848 |
24-04-19 | 0.3075 | +6.03% | 53,099 |
24-04-18 | 0.29 | -6.45% | 49,179 |
24-04-17 | 0.31 | +3.33% | 31,513 |
24-04-16 | 0.3 | -0.40% | 105,283 |
End-of-day quote Nasdaq, April 18, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-53.41% | 12.85M | |
+2.49% | 96.73B | |
-0.55% | 21.31B | |
-16.61% | 21.21B | |
-5.15% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |
- Stock Market
- Equities
- SNTI Stock